Lysosomes and endoplasmic reticulum: Targets for improved, selective anticancer therapy

Drug Resistance Updates

Volumn 8, Issue 4, 2005, Pages 199-204

  Linder, Stig ^a   Shoshan, Maria C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Bortezomib; Cell organelles; Endoplasmic reticulum; Lysosomes; Proteasome

Indexed keywords

ANTINEOPLASTIC AGENT; BORTEZOMIB; PROTEASOME;

APOPTOSIS; CANCER; CANCER CHEMOTHERAPY; CELL DAMAGE; CELL DEATH; CELL ORGANELLE; CELL PROLIFERATION; DNA DAMAGE; DRUG SENSITIVITY; DRUG TARGETING; ENDOPLASMIC RETICULUM; ENZYME RELEASE; GENETIC TRANSFORMATION; HUMAN; HYPOXIA; LYSOSOME; NECROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; TUMOR CELL;

EID: 26844570219     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drup.2005.06.004     Document Type: Article

References (66)

1. S.M. Ali, S.K. Chee, G.Y. Yuen, and M. Olivo Photodynamic therapy induced Fas-mediated apoptosis in human carcinoma cells Int. J. Mol. Med. 9 2002 257 270
2. J.W. Brewer, J.L. Cleveland, and L.M. Hendershot A pathway distinct from the mammalian unfolded protein response regulates expression of endoplasmic reticulum chaperones in non-stressed cells EMBO J. 16 1997 7207 7216
3. U.T. Brunk, and I. Svensson Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak Redox Rep. 4 1999 3 11
4. W. Bursch The autophagosomal-lysosomal compartment in programmed cell death Cell Death Differ. 8 2001 569 581
5. K.T. Bush, A.L. Goldberg, and S.K. Nigam Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance J. Biol. Chem. 272 1997 9086 9092
6. X. Chen, Y. Ding, C.G. Liu, S. Mikhail, and C.S. Yang Overexpression of glucose-regulated protein 94 (Grp94) in esophageal adenocarcinomas of a rat surgical model and humans Carcinogenesis 23 2002 123 130
7. T. Cirman, K. Oresic, G.D. Mazovec, V. Turk, J.C. Reed, R.M. Myers, G.S. Salvesen, and B. Turk Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins J. Biol. Chem. 279 2004 3578 3587
8. C. de Duve Lysosomes revisited Eur. J. Biochem. 137 1983 391 397
9. S.R. Denmeade, C.M. Jakobsen, S. Janssen, S.R. Khan, E.S. Garrett, H. Lilja, S.B. Christensen, and J.T. Isaacs Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer J. Natl. Cancer Inst. 95 2003 990 1000
10. A.L. Edinger, and C.B. Thompson Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake Mol. Biol. Cell 13 2002 2276 2288
11. L. Ellgaard, M. Molinari, and A. Helenius Setting the standards: quality control in the secretory pathway Science 286 1999 1882 1888
12. L. Emert-Sedlak, S. Shangary, A. Rabinovitz, M.B. Miranda, S.M. Delach, and D.E. Johnson Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death Mol. Cancer Ther. 4 2005 733 742
13. H. Erdal, M. Berndtsson, J. Castro, U. Brunk, M.C. Shoshan, and S. Linder Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis Proc. Natl. Acad. Sci. U.S.A. 102 2005 192 197
14. N. Fehrenbacher, M. Gyrd-Hansen, B. Poulsen, U. Felbor, T. Kallunki, M. Boes, E. Weber, M. Leist, and M. Jaattela Sensitization to the lysosomal cell death pathway upon immortalization and transformation Cancer Res. 64 2004 5301 5310
15. N. Fehrenbacher, and M. Jaattela Lysosomes as targets for cancer therapy Cancer Res. 65 2005 2993 2995
16. L. Foghsgaard, D. Wissing, D. Mauch, U. Lademann, L. Bastholm, M. Boes, F. Elling, M. Leist, and M. Jaattela Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor J. Cell Biol. 153 2001 999 1010
17. A. Fribley, Q. Zeng, and C.Y. Wang Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells Mol. Cell. Biol. 24 2004 9695 9704
18. M. Gasco, and T. Crook P53 family members and chemoresistance in cancer: what we know and what we need to know Drug Resist. Update 6 2003 323 328
19. K. Glunde, S.E. Guggino, M. Solaiyappan, A.P. Pathak, Y. Ichikawa, and Z.M. Bhujwalla Extracellular acidification alters lysosomal trafficking in human breast cancer cells Neoplasia 5 2003 533 545
20. T.G. Graeber, J.F. Peterson, M. Tsai, K. Monica, A.J. Fornace Jr., and A.J. Giaccia Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status Mol. Cell. Biol. 14 1994 6264 6277
21. M.E. Guicciardi, J. Deussing, H. Miyoshi, S.F. Bronk, P.A. Svingen, C. Peters, S.H. Kaufmann, and G.J. Gores Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c J. Clin. Invest. 106 2000 1127 1137
22. M.E. Guicciardi, M. Leist, and G.J. Gores Lysosomes in cell death Oncogene 23 2004 2881 2890
23. C.M. Haynes, E.A. Titus, and A.A. Cooper Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death Mol. Cell 15 2004 767 776
24. Q. He, J. Montalbano, C. Corcoran, W. Jin, Y. Huang, and M.S. Sheikh Effect of Bax deficiency on death receptor 5 and mitochondrial pathways during endoplasmic reticulum calcium pool depletion-induced apoptosis Oncogene 22 2003 2674 2679
25. J. Hitomi, T. Katayama, Y. Eguchi, T. Kudo, M. Taniguchi, Y. Koyama, T. Manabe, S. Yamagishi, Y. Bando, K. Imaizumi, Y. Tsujimoto, and M. Tohyama Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death J. Cell Biol. 165 2004 347 356
26. L. Huang, J. Xu, K. Li, M.H. Zheng, and S.M. Kumta Thapsigargin potentiates TRAIL-induced apoptosis in giant cell tumor of bone Bone 34 2004 971 981
27. M. Hägg, M. Berndtsson, A. Mandic, R. Zhou, M.C. Shoshan, and S. Linder Induction of endoplasmic reticulum stress by ellipticine plant alkaloids Mol. Cancer Ther. 3 2004 489 497
28. Y.M. Jang, S. Kendaiah, B. Drew, T. Phillips, C. Selman, D. Julian, and C. Leeuwenburgh Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats FEBS Lett. 577 2004 483 490
29. A.C. Johansson, H. Steen, K. Ollinger, and K. Roberg Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine Cell. Death Differ. 10 2003 1253 1259
30. S.J. Korsmeyer, M.C. Wei, M. Saito, S. Weiler, K.J. Oh, and P.H. Schlesinger Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c Cell. Death Differ. 7 2000 1166 1173
31. A.H. Lee, N.N. Iwakoshi, K.C. Anderson, and L.H. Glimcher Proteasome inhibitors disrupt the unfolded protein response in myeloma cells Proc. Natl. Acad. Sci. U.S.A. 100 2003 9946 9951
32. A.S. Lee The glucose-regulated proteins: stress induction and clinical applications Trends Biochem. Sci. 26 2001 504 510
33. M. Leist, and M. Jaattela Triggering of apoptosis by cathepsins Cell. Death Differ. 8 2001 324 326
34. Z.P. Lin, Y.C. Boller, S.M. Amer, R.L. Russell, K.A. Pacelli, S.R. Patierno, and K.A. Kennedy Prevention of brefeldin A-induced resistance to teniposide by the proteasome inhibitor MG-132: involvement of NF-kappaB activation in drug resistance Cancer Res. 58 1998 3059 3065
35. E. Little, M. Ramakrishnan, B. Roy, G. Gazit, and A.S. Lee The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications Crit. Rev. Eukaryot. Gene Exp. 4 1994 1 18
36. J.J. Lum, D.E. Bauer, M. Kong, M.H. Harris, C. Li, T. Lindsten, and C.B. Thompson Growth factor regulation of autophagy and cell survival in the absence of apoptosis Cell 120 2005 237 248
37. A. Mandic, J. Hansson, S. Linder, and M.C. Shoshan Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling J. Biol. Chem. 278 2003 9100 9106
38. A. Mandic, K. Viktorsson, L. Strandberg, T. Heiden, J. Hansson, S. Linder, and M.C. Shoshan Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis Mol. Cell. Biol. 22 2002 3003 3013
39. S. Mocellin, C.R. Rossi, P. Pilati, and D. Nitti Tumor necrosis factor, cancer and anticancer therapy Cytokine Growth Factor Rev. 16 2005 35 53
40. T. Nakagawa, and J. Yuan Cross-talk between two cysteine protease families: activation of caspase-12 by calpain in apoptosis J. Cell Biol. 150 2000 887 894
41. H. Nishitoh, A. Matsuzawa, K. Tobiume, K. Saegusa, K. Takeda, K. Inoue, S. Hori, A. Kakizuka, and H. Ichijo ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats Genes Dev. 16 2002 1345 1355
42. I. Noda, S. Fujieda, M. Seki, N. Tanaka, H. Sunaga, T. Ohtsubo, H. Tsuzuki, G.K. Fan, and H. Saito Inhibition of N-linked glycosylation by tunicamycin enhances sensitivity to cisplatin in human head-and-neck carcinoma cells Int. J. Cancer 80 1999 279 284
43. K. Ono, S.O. Kim, and J. Han Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor alpha-induced cell death Mol. Cell. Biol. 23 2003 665 676
44. H.R. Park, A. Tomida, S. Sato, Y. Tsukumo, J. Yun, T. Yamori, Y. Hayakawa, T. Tsuruo, and K. Shin-ya Effect on tumor cells of blocking survival response to glucose deprivation J. Natl. Cancer Inst. 96 2004 1300 1310
45. H. Pelicano, D. Carney, and P. Huang ROS stress in cancer cells and therapeutic implications Drug Resist. Update 7 2004 97 110
46. J. Piette, C. Volanti, A. Vantieghem, J.Y. Matroule, Y. Habraken, and P. Agostinis Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers Biochem. Pharmacol. 66 2003 1651 1659
47. R.K. Reddy, C. Mao, P. Baumeister, R.C. Austin, R.J. Kaufman, and A.S. Lee Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation J. Biol. Chem. 278 2003 20915 20924
48. K. Roberg, K. Kagedal, and K. Ollinger Microinjection of cathepsin D induces caspase-dependent apoptosis in fibroblasts Am. J. Pathol. 161 2002 89 96
49. H. Rochefort, M. Garcia, M. Glondu, V. Laurent, E. Liaudet, J.M. Rey, and P. Roger Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview Clin. Chim. Acta 291 2000 157 170
50. A. Ruiz-Vela, G. Gonzalez de Buitrago, and A.C. Martinez Implication of calpain in caspase activation during B cell clonal deletion EMBO J. 18 1999 4988 4998
51. M.S. Song, Y.K. Park, J.H. Lee, and K. Park Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade Cancer Res. 61 2001 8322 8330
52. F. Spyratos, J.P. Brouillet, A. Defrenne, K. Hacedne, J. Rouesse, T. Maudelonde, M. Brunet, C. Andrieu, A. Desplaces, and H. Rochefort Cathepsin D: an independent prognostic factor for metastasis of breast cancer Lancet ii 1989 1115 1118
53. P. Storz Reactive oxygen species in tumor progression Front. Biosci. 10 2005 1881 1896
54. V. Turk, and W. Bode The cystatins: protein inhibitors of cysteine proteinases FEBS Lett. 285 1991 213 219
55. V. Turk, B. Turk, and D. Turk Lysosomal cysteine proteases: facts and opportunities EMBO J. 20 2001 4629 4633
56. F. Urano, X. Wang, A. Bertolotti, Y. Zhang, P. Chung, H.P. Harding, and D. Ron Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1 Science 287 2000 664 666
57. I. Vasilevskaya, and P.J. O'Dwyer Role of Jun and Jun kinase in resistance of cancer cells to therapy Drug Resist. Update 6 2003 147 156
58. H. Walczak, R.E. Miller, K. Ariail, B. Gliniak, T.S. Griffith, M. Kubin, W. Chin, J. Jones, A. Woodward, T. Le, C. Smith, P. Smolak, R.G. Goodwin, C.T. Rauch, J.C. Schuh, and D.H. Lynch Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat. Med. 5 1999 157 163
59. K.A. West, S.S. Castillo, and P.A. Dennis Activation of the PI3K/Akt pathway and chemotherapeutic resistance Drug Resist. Update 5 2002 234 248
60. N.W. Werneburg, M.E. Guicciardi, S.F. Bronk, and G.J. Gores Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent Am. J. Physiol. Gastrointest. Liver Physiol. 283 2002 G947 G956
61. D.E. Wood, A. Thomas, L.A. Devi, Y. Berman, R.C. Beavis, J.C. Reed, and E.W. Newcomb Bax cleavage is mediated by calpain during drug-induced apoptosis Oncogene 17 1998 1069 1078
62. H. Yamaguchi, and H.G. Wang CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells J. Biol. Chem. 279 2004 45495 45502
63. S. Yan, M. Sameni, and B.F. Sloane Cathepsin B and human tumor progression Biol. Chem. 379 1998 113 123
64. H. Yoshida, K. Haze, H. Yanagi, T. Yura, and K. Mori Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins: involvement of basic leucine zipper transcription factors J. Biol. Chem. 273 1998 33741 33749
65. X.M. Yuan, W. Li, H. Dalen, J. Lotem, R. Kama, L. Sachs, and U.T. Brunk Lysosomal destabilization in p53-induced apoptosis Proc. Natl. Acad. Sci. U.S.A. 99 2002 6286 6291
66. 2-mediated damage to lysosomal membranes of J-774 cells Free Radic. Res. Commun. 18 1993 71 85